Exome sequencing studies have implicated loss of function (LoF) mutations in the SETD1A gene that increase susceptibility for a number of neurodevelopmental disorders (NDD) and conditions, including developmental delay, early-onset epilepsy, intellectual disability and schizophrenia [13–16]. This evidence concerns the gene SETD1A and schizophrenia.